XML 33 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Stockholder Equity - USD ($)
$ in Millions
Total
Total stockholder equity
Common stock 
Capital surplus
(Accumulated deficit) Retained earnings
Treasury stock
Cumulative translation adjustment
Defined benefit postretirement plans
Cash flow hedging derivative
Non-controlling interest
Pension adjustments, tax benefit (expense) $ (0.1)                  
Change in cumulative translation adjustment, tax expense (benefit) (1.1)                  
Derivative financial instrument, tax expense (benefit) (0.1)                  
Balance at beginning of period at Dec. 31, 2020 3,583.9 $ 3,525.6 $ 0.0 $ 4,310.2 $ (690.1) $ 0.0 $ 26.2 $ (120.3) $ (0.4) $ 58.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (23.3) (25.0)     (25.0)         1.7
Shares issued for Bisnode acquisition 158.9 158.9   158.9            
Equity-based compensation plans 5.9 5.9   6.2   (0.3)        
Pension adjustments, net of tax expense (benefit) 0.4 0.4           0.4    
Change in cumulative translation adjustment, net of tax expense (benefit) (49.3) [1] (50.0)         (50.0)     0.7
Derivative financial instruments, net of tax expense (benefit) 1.8 [2] 1.8             1.8  
Payment to non-controlling interest (0.1)                 (0.1)
Balance at end of period at Mar. 31, 2021 3,678.2 3,617.6 0.0 4,475.3 (715.1) (0.3) (23.8) (119.9) 1.4 60.6
Pension adjustments, tax benefit (expense) 0.1                  
Change in cumulative translation adjustment, tax expense (benefit) 0.9                  
Derivative financial instrument, tax expense (benefit) 8.7                  
Balance at beginning of period at Dec. 31, 2021 3,745.3 3,681.2 0.0 4,500.4 (761.8) (0.3) (52.6) (11.9) 7.4 64.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (29.8) (31.3)     (31.3)         1.5
Equity-based compensation plans 6.4 6.4   6.4   0.0        
Pension adjustments, net of tax expense (benefit) (0.1) (0.1)           (0.1)    
Change in cumulative translation adjustment, net of tax expense (benefit) (36.3) [1] (36.3)         (36.3)     0.0
Derivative financial instruments, net of tax expense (benefit) 23.6 [2] 23.6             23.6  
Payment to non-controlling interest (0.2)                 (0.2)
Balance at end of period at Mar. 31, 2022 $ 3,708.9 $ 3,643.5 $ 0.0 $ 4,506.8 $ (793.1) $ (0.3) $ (88.9) $ (12.0) $ 31.0 $ 65.4
[1] Tax Expense (Benefit) of $(0.9) million and $1.1 million for the three months ended March 31, 2022 and 2021, respectively.
[2] Tax Expense (Benefit) of $8.7 million and $(0.1) million for the three months ended March 31, 2022 and 2021, respectively.